Tasigna
(Nilotinib)
(200 mg)
(28)
(Tablets)
Tasigna (nilotinib) 200 mg 28 tab. Luzius India
Article:
Indications:
Tablets 200 mg
- Treatment of newly diagnosed chronic phase chronic myeloid leukemia (Ph + CML), in adult patients with the Philadelphia chromosome.
- Treatment of chronic and accelerated phase (FA) of chronic myeloid leukemia (Ph + CML) in adult patients with the Philadelphia chromosome, in case of resistance or intolerance to previous therapy, including imatinib therapy.
-
Commercial name:Tasigna
-
Сhemical name:Nilotinib
-
Dosage:200 mg
-
Quantity:28
-
Release form:Tablets
No reviews yet